Jorge Jimenez, MD
Retina Specialist · Baton Rouge, LANPI 1518353168
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for retina specialist clinicians in LA, where the typical reported total is $2,679.
Across 77 payments — averaging $34.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$511
- Genentech USA, Inc.$482
- Astellas Pharma US Inc$425
- Bausch & Lomb Americas Inc.$250
- Regeneron Healthcare Solutions, Inc.$161
- Apellis Pharmaceuticals, Inc.$157
- plus $694 from 11 others
What the payments were for
- Food & beverage$2,679100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 6 | $511 |
| Genentech USA, Inc. | 13 | $482 |
| Astellas Pharma US Inc | 15 | $425 |
| Bausch & Lomb Americas Inc. | 14 | $250 |
| Regeneron Healthcare Solutions, Inc. | 3 | $161 |
| Apellis Pharmaceuticals, Inc. | 4 | $157 |
| Notal Vision, Inc. | 4 | $123 |
| AbbVie | 5 | $112 |
| Eyepoint US, Inc. | 1 | $108 |
| ANI Pharmaceuticals, Inc. | 4 | $104 |
| CSL Behring | 1 | $60 |
| Iridex Corporation | 1 | $48 |
| Harrow Eye, LLC | 2 | $43 |
| Coherus Oncology, Inc. | 1 | $30 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Alimera Sciences, Inc. | 1 | $21 |
| Biogen | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,679 in reported general payments places this provider in the 50th percentile of 30 retina specialist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 374 | $18,240 |
| Difluprednate | 37 | $3,614 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 156 | $2,417 |
| Brimonidine Tartrate | 88 | $1,170 |
| Ofloxacin | 85 | $975 |
| Latanoprost | 67 | $821 |
| Ketorolac Tromethamine | 24 | $812 |
| Dorzolamide Hcl | 44 | $700 |
| Atropine Sulfate | 14 | $460 |
| ErythromycinErythromycin Base | 36 | $408 |
| Prednisone | 36 | $297 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $170 |
| Timolol Maleate | 24 | $157 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Baton Rouge
- Adam JanotBaton Rouge$8K
- Daniel SalisburyBaton Rouge$7K
- Jamie HatcherBaton Rouge$1K
- John CreedBaton Rouge$442
- Donald MazzullaNew Orleans$215K
- Sidharth PuriNew Orleans$32K
- Gwen CousinsMetairie$10K
- Frank CulottaLafayette$9K
- Scott GauthreauxLafayette$7K
- Brett BuddenMetairie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.